US FDA Waits Until December To Enforce Unique Device Identifier Database For Low-Risk Devices
Agency won’t require manufacturers to submit class I devices to the database for an extra 75 days, and doesn't plan to enforce GUDID regulations against consumer health products.
You may also be interested in...
Due to the ongoing coronavirus crisis, regulators have put pushed back deadlines for meeting UDI requirements. In some instances, they will no longer require direct-mark UDI information if it can be garnered from other data on the device.
The US Food and Drug Administration and the Veterans Health Administration are partnering to create tools that can help novel technology reach patients more quickly and easily.
The US FDA has approved additional indications for Thermo Fisher Scientific’s Oncomine Dx Target, allowing the companion diagnostic to be used to detect more varieties of lung and thyroid cancer.